DAIICHI SANKYO, INC. for DAIICHI SANKYO INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Discussions related to drug importation and IPAB (S.319, S. 688, H.R. 147, H.R.2112/Admt769) Discussions related to budget and debt ceiling (S.365) Discussions regarding drug shortages (H.R. 2245, S. 296)
Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH LEE WRIGHT | — |
Medicare/Medicaid MMM
Discussions regarding Medicare Part D (H.R.2693/Joint Committee on Deficit Reduction)
Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH LEE WRIGHT | — |
Copyright/Patent/Trademark CPT
Discussions regarding intellectual property protection and innovation. Discussions related to patent settlements (S. 27)
Foreign entity interest: To the degree that public policies, either laws or regulations, commercially impact Daiichi Sankyo, Inc. so too, Daiichi Sankyo Co., LTD, the parent company, will likewise be impacted.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANCE GILGORE | — |
| ELIZABETH LEE WRIGHT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.